DUCTAL ADENOCARCINOMA OF PANCREAS

DUCTAL ADENOCARCINOMA OF PANCREAS was reported 277 times

DUCTAL ADENOCARCINOMA OF PANCREAS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nucleoside Metabolic Inhibitor [EPC] 122 0.0004
1 Platinum-based Drug [EPC] 115 0.0004
2 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
3 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 5 0.0002
4 Glinide [EPC] 2 0.0002
5 Microtubule Inhibitor [EPC] 33 0.0002
6 CD30-directed Immunoconjugate [EPC] 2 0.0002
7 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
8 Provitamin D2 Compound [EPC] 3 0.0001
9 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0001
10 Nonergot Dopamine Agonist [EPC] 1 0.0001
11 Dipeptidyl Peptidase 4 Inhibitor [EPC] 2 0.0001
12 GLP-1 Receptor Agonist [EPC] 23 0.0001
13 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
14 Antimetabolite Immunosuppressant [EPC] 1 0.0000
15 Integrin Receptor Antagonist [EPC] 4 0.0000
16 Serotonin Reuptake Inhibitor [EPC] 4 0.0000
17 Aluminum Complex [EPC] 1 0.0000
18 Interleukin-12 Antagonist [EPC] 4 0.0000
19 Interleukin-23 Antagonist [EPC] 4 0.0000
20 Serotonin-3 Receptor Antagonist [EPC] 5 0.0000
21 CD20-directed Cytolytic Antibody [EPC] 11 0.0000
22 Leukotriene Receptor Antagonist [EPC] 1 0.0000
23 Phenothiazine [EPC] 1 0.0000
24 Sulfonylurea [EPC] 4 0.0000
25 Factor Xa Inhibitor [EPC] 8 0.0000
26 Insulin Analog [EPC] 13 0.0000
27 Alkylating Drug [EPC] 7 0.0000
28 Interleukin-17A Antagonist [EPC] 1 0.0000
29 Aminoglycoside Antibacterial [EPC] 1 0.0000
30 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
31 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
32 Folate Analog Metabolic Inhibitor [EPC] 9 0.0000
33 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
34 Folate Analog [EPC] 1 0.0000
35 Ester Local Anesthetic [EPC] 1 0.0000
36 Vitamin A [EPC] 1 0.0000
37 beta-Adrenergic Blocker [EPC] 6 0.0000
38 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 2 0.0000
39 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
40 Proton Pump Inhibitor [EPC] 10 0.0000
41 Vitamin D [EPC] 5 0.0000
42 Nicotinic Acid [EPC] 1 0.0000
43 Antidote [EPC] 1 0.0000
44 Platelet Aggregation Inhibitor [EPC] 9 0.0000
45 Angiotensin 2 Receptor Blocker [EPC] 5 0.0000
46 Fluoroquinolone Antibacterial [EPC] 2 0.0000
47 Vitamin B12 [EPC] 5 0.0000
48 Nitroimidazole Antimicrobial [EPC] 1 0.0000
49 Tetracycline-class Drug [EPC] 1 0.0000
50 Leukocyte Growth Factor [EPC] 2 0.0000
51 Cardiac Glycoside [EPC] 1 0.0000
52 HER2/neu Receptor Antagonist [EPC] 1 0.0000
53 Topoisomerase Inhibitor [EPC] 1 0.0000
54 Non-Standardized Chemical Allergen [EPC] 1 0.0000
55 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
56 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
57 Vitamin C [EPC] 5 0.0000
58 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
59 Amide Local Anesthetic [EPC] 1 0.0000
60 Nitrate Vasodilator [EPC] 1 0.0000
61 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
62 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
63 Osmotic Laxative [EPC] 3 0.0000
64 Purine Antimetabolite [EPC] 1 0.0000
65 Corticosteroid [EPC] 13 0.0000
66 Antiarrhythmic [EPC] 1 0.0000
67 Thiazide Diuretic [EPC] 2 0.0000
68 Nonsteroidal Anti-inflammatory Drug [EPC] 12 0.0000
69 Loop Diuretic [EPC] 4 0.0000
70 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
71 Opioid Agonist [EPC] 2 0.0000
72 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
73 alpha-Adrenergic Blocker [EPC] 1 0.0000
74 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
75 Calcium [EPC] 1 0.0000
76 Azole Antifungal [EPC] 1 0.0000
77 Janus Kinase Inhibitor [EPC] 1 0.0000
78 Thalidomide Analog [EPC] 3 0.0000
79 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
80 Estrogen [EPC] 1 0.0000
81 Endothelin Receptor Antagonist [EPC] 1 0.0000
82 Benzodiazepine [EPC] 2 0.0000
83 Atypical Antipsychotic [EPC] 1 0.0000